[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100540768":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":30,"locations":36,"responsibleParty":96,"collaborators":100,"id":106,"slug":107,"hasResults":108,"nctId":109,"briefTitle":110,"officialTitle":111,"acronym":25,"eligibilityCriteria":112,"healthyVolunteers":108,"sex":113,"minAge":114,"maxAge":115,"enrollmentInfo":116,"targetDuration":25,"studyType":119,"phases":120,"briefSummary":122,"conditions":123,"keywords":125,"overallStatus":39,"whyStopped":25,"lastUpdateSubmitDate":127,"lastUpdatePostDateStruct":128,"startDateStruct":131,"completionDateStruct":133,"leadSponsor":135,"locationsCount":136},{"fullName":5,"class":6},"Kuopio University Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Immediate ending","EXPERIMENTAL","High flow is ended immediately",[13],"Other: High flow nasal cannula immediate ending",{"label":15,"type":16,"description":17,"interventionNames":18},"Weaning","ACTIVE_COMPARATOR","High flow is ended by gradually reducing the flow rate",[19],"Other: High flow nasal cannula weaning",[21,26],{"type":6,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"High flow nasal cannula immediate ending","High flow is immediately ended",[9],null,{"type":6,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"High flow nasal cannula weaning","High flow is gradually weaned by reducing the flow rate",[15],[31],{"name":32,"role":33,"phone":34,"phoneExt":25,"email":35},"Ilari Kuitunen, MD, PhD","CONTACT","+358447174910","ilari.kuitunen@uef.fi",[37,54,67,83],{"facility":38,"status":39,"city":40,"state":25,"zip":25,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Siun Sote","RECRUITING","Joensuu","Finland","FI",{"type":44,"coordinates":45},"Point",[46,47],29.76316,62.60118,{"lat":47,"lon":46},[50],{"name":51,"role":33,"phone":52,"phoneExt":25,"email":53},"Paula Widgren, MD, PhD","0045813 330 8285","paula.widgren@siunsote.fi",{"facility":55,"status":39,"city":56,"state":25,"zip":25,"country":41,"countryCode":42,"cosmosGeoPoint":57,"geoPoint":61,"contacts":62},"Central Finland Hospital District","Jyväskylä",{"type":44,"coordinates":58},[59,60],25.72088,62.24147,{"lat":60,"lon":59},[63],{"name":64,"role":33,"phone":65,"phoneExt":25,"email":66},"Milla Pitkänen, MD","0035814 2691811","milla.pitkanen@hyvaks.fi",{"facility":5,"status":39,"city":68,"state":25,"zip":25,"country":41,"countryCode":42,"cosmosGeoPoint":69,"geoPoint":73,"contacts":74},"Kuopio",{"type":44,"coordinates":70},[71,72],27.67703,62.89238,{"lat":72,"lon":71},[75,76,78,81],{"name":32,"role":33,"phone":34,"phoneExt":25,"email":35},{"name":77,"role":33,"phone":25,"phoneExt":25,"email":25},"Marjo Renko, Professor",{"name":79,"role":80,"phone":25,"phoneExt":25,"email":25},"Katri Backman, MD, PhD","SUB_INVESTIGATOR",{"name":82,"role":80,"phone":25,"phoneExt":25,"email":25},"Miika Arvonen, MD, PhD",{"facility":84,"status":39,"city":85,"state":25,"zip":25,"country":41,"countryCode":42,"cosmosGeoPoint":86,"geoPoint":90,"contacts":91},"Mikkeli Central Hospital","Mikkeli",{"type":44,"coordinates":87},[88,89],27.27227,61.68857,{"lat":89,"lon":88},[92],{"name":93,"role":33,"phone":94,"phoneExt":25,"email":95},"Nicole Weisshoff, MD","0035815 3511","nicole.weisshoff@etelasavonha.fi",{"type":97,"investigatorFullName":98,"investigatorTitle":99,"investigatorAffiliation":5,"oldNameTitle":25,"oldOrganization":25},"PRINCIPAL_INVESTIGATOR","Ilari Kuitunen","Associate Professor",[101,102,103],{"name":55,"class":6},{"name":84,"class":6},{"name":104,"class":105},"Siun sote","UNKNOWN","100540768","high-flow-nasal-cannula-weaning-in-acute-bronchiolitis-100540768",false,"NCT06321133","High Flow Nasal Cannula Weaning in Acute Bronchiolitis","High Flow Nasal Cannula Weaning in Acute Bronchiolitis - an Open-label Randomized Controlled Trials","Inclusion Criteria:\n\n* Clinically diagnosed acute bronchiolitis\n* High flow nasal cannula treatment has lasted for at least 12 hours\n* Measured saturation 95 or more with room air\n* High flow rate is maximum 2l\u002Fkg\u002Fmin\n* The treating doctors considers the infant suitable to be without high flow\n\nExclusion Criteria:\n\n* Major congenital anomaly of lungs, hearts or diaphragm\n* Bacterial pneumonia\n* Parents do not give consent","ALL","0 Months","12 Months",{"count":117,"type":118},50,"ESTIMATED","INTERVENTIONAL",[121],"NA","The goal of this clinical study is to compared two different strategies to end high flow nasal cannula treatment in acute bronchiolitis. This study compared the immediate ending of high flow treatment to weaning strategy, in which the flow rate is gradually decreased. The aim is to assess if the immediate ending shortens the hospitalization time and whether it is a safe strategy.",[124],"Acute Bronchiolitis",[126],"Acute bronchiolitis","2025-08-26",{"date":129,"type":130},"2025-09-03","ACTUAL",{"date":132,"type":130},"2024-02-13",{"date":134,"type":118},"2028-12-31",{"name":5,"class":6},4]